Early Detection and Treatment of Altered Growth and Puberty in Children and Adolescents with Vertically-Acquired Hiv-1 Infection: It's Time to Think about it

De Martino M. Tovo P.A. Galli L. , 1994. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 343:191.

De Martino M. Zappa M. Galli L. Rossi M.E. Vierucci A. , 1996. Does the classification system fit disease progression in perinatal human immunodeficiency virus infection? Acta Paediatr. 85:724.

Laue L. Pizzo P.A. Cutler G.B. , 1992. Mechanism of delayed puberty in adolescents with HIV infection. Pediatr. Res. 30:79A.

Schwartz L.J. St Louis Y. Wu R. Wiznia A. Rubinstein A. Saenger P. , 1991. Endocrine function in children with human immunodeficiency infection. Am. J. Dis. Child. 145:330.

Jospe N. Powell K.R. , 1990. Growth hormone deficiency in a 8-year-old girl with human immunodeficiency virus infection. Pediatrics 86:309.

Sullivan W.M. Kelley G.G. O'Connor P.G. , 1992. Hypopituitarism associated with a hypothalamic CMV infection in a patient with AIDS. Am. J. Med. 92:221.

Milligan S.A. Katz M.S. Craven P.C. , 1984. Toxoplasmosis presenting as a panhypopituitarism in a patient with the acquired immune deficiency syndrome. Am. J. Med. 77:760.

Merril J.E. 1992. Cytokines and retroviruses. Clin. Immunol. Immunopathol. 64:23.

Geffner M.E. Yeh D.Y. Landaw J. , 1993. In vitro insulin-like growth factor-1, growth hormone, and insulin resistance occurs in symptomatic human immunodeficiency virus-1-infected children. Pediatr. Res. 34:66.

Kaufman F.R. Gertner J.M. Sleeper L.A. Donfield S.M. , 1997. Growth hormone secretion in HIV-positive versus HIV-negative hemophilic males with abnormal growth and pubertal development. J. Acquir. Immune Defic. Syndr. Hum. Retrovir. 15:137.

Kumar M. Kumar A.M. Morgan R. Szapocznik J. Eisdorfer C. , 1993. Abnormal pituitary-adrenocortical response in early HIV-1 infection. J. Acquir. Immune Defic. Syndr. 6:61.

Lee P.D.K. Pivarnik J.M. Bukar J.G. , 1996. A randomized, placebo-controlled trial of combined insulinlike growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection. J. Clin. Endocrinol. Metab. 81:2968.

Krentz A.J. Foster F.T. Crist D.M. Finn K. Johnson L.Z. Boyle P.J. , 1993. Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. J. Acquir. Immune Defic. Syndr. 6:245.

Clarick R.H. Hanekom W.A. Yogev R. Wick E.G. Chad . 1997. Megestrol acetate treatment of growth failure in children infected with human immunodeficiency virus. Pediatrics 99:354.